Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MD Michelle Dubey Yousif Capital Management LLC | 23,681 | $226,622.48 | $284,408.81 | $57,786.33 | 25.5% |
| Health Care Providers & Services Industry | Healthcare Sector | Michael Sen CEO | OTC PINK Exchange | 35804M105 CUSIP |
| DE Country | 177,783 Employees | 26 May 2026 Last Dividend | 5 Aug 2014 Last Split | - IPO Date |
Fresenius SE & Co. KGaA is a leading health care company specializing in providing a wide range of products and services for chronically ill patients. With its operations divided into four primary segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed, the company caters to the varied needs of patients worldwide. Fresenius Medical Care focuses on offering solutions for those suffering from chronic kidney failure, while Fresenius Kabi is dedicated to the therapy and care of critically and chronically ill patients through its range of drugs, nutrition products, and medical technologies. Fresenius Helios operates clinical and nursing care facilities, and Fresenius Vamed delivers services for hospitals and other healthcare facilities, including operational management. Established in 1912 and formerly known as Fresenius SE, the company underwent a name change in January 2011 to Fresenius SE & Co. KGaA. Headquartered in Bad Homburg vor der Höhe, Germany, Fresenius stands as a testament to innovation and dedication in the healthcare sector.